UnitedHealth Group Inc.

UnitedHealth Group is a health care company. The company has four reportable segments across its two business platforms, UnitedHealthcare and Optum: UnitedHealthcare, which provides health care benefits to an array of customers and markets through its UnitedHealthcare Employer & Individual, UnitedHealthcare Medicare & Retirement, UnitedHealthcare Community & State and UnitedHealthcare Global; OptumHealth, which serves the physical, emotional and health-related financial needs of individuals; OptumInsight, which provides services, technology and health care knowledge to main participants in the health care industry; and OptumRx, which provides pharmacy care services and programs.
  • TickerUNH
  • ISINUS91324P1021
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States
UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group : 1 director

A director at UnitedHealth Group sold 7,000 shares at 415.695USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group Incorporated: 2021 results to date exceeding expect...

Solid earnings results in Q2 2021 support UnitedHealth's strong credit profile

UNH UnitedHealth Gr... (Health Care)

Moody’s rates UnitedHealth Group’s senior notes A3

Approximately $5 billion of new debt securities rated New York , May 17, 2021 – Moody's Investors Service has assigned an A3 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH, senior debt at A3) planned issuance of $5.0 billion of senior unsecured debt...

Valens Research
  • Valens Research
UNH UnitedHealth Gr... (Health Care)

UNH - Embedded Expectations Analysis - 2021 05 14

UnitedHealth Group Incorporated (UNH:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 23.3x Uniform P/E. At these levels, the market has expectations for profitability to remain stable, but management may be concerned about their OptumCare platform, digital solutions, and the potential disruption of their Change Health acquisition Specifically, management may lack confidence in their ability to sustain adjusted earnings per share (EPS) growth, maintain patient growth under their managed Medicaid programs, and increase fully capitated programs, ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group : 1 director

A director at UnitedHealth Group sold 7,000 shares at 415.695USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group Incorporated: 2021 results to date exceeding expect...

Solid earnings results in Q2 2021 support UnitedHealth's strong credit profile

UNH UnitedHealth Gr... (Health Care)

Moody’s rates UnitedHealth Group’s senior notes A3

Approximately $5 billion of new debt securities rated New York , May 17, 2021 – Moody's Investors Service has assigned an A3 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH, senior debt at A3) planned issuance of $5.0 billion of senior unsecured debt...

Valens Research
  • Valens Research
UNH UnitedHealth Gr... (Health Care)

UNH - Embedded Expectations Analysis - 2021 05 14

UnitedHealth Group Incorporated (UNH:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 23.3x Uniform P/E. At these levels, the market has expectations for profitability to remain stable, but management may be concerned about their OptumCare platform, digital solutions, and the potential disruption of their Change Health acquisition Specifically, management may lack confidence in their ability to sustain adjusted earnings per share (EPS) growth, maintain patient growth under their managed Medicaid programs, and increase fully capitated programs, ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group : 1 director

A director at UnitedHealth Group sold 7,000 shares at 415.695USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group Incorporated: 2021 results to date exceeding expect...

Solid earnings results in Q2 2021 support UnitedHealth's strong credit profile

UNH UnitedHealth Gr... (Health Care)

Moody’s rates UnitedHealth Group’s senior notes A3

Approximately $5 billion of new debt securities rated New York , May 17, 2021 – Moody's Investors Service has assigned an A3 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH, senior debt at A3) planned issuance of $5.0 billion of senior unsecured debt...

Valens Research
  • Valens Research
UNH UnitedHealth Gr... (Health Care)

UNH - Embedded Expectations Analysis - 2021 05 14

UnitedHealth Group Incorporated (UNH:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 23.3x Uniform P/E. At these levels, the market has expectations for profitability to remain stable, but management may be concerned about their OptumCare platform, digital solutions, and the potential disruption of their Change Health acquisition Specifically, management may lack confidence in their ability to sustain adjusted earnings per share (EPS) growth, maintain patient growth under their managed Medicaid programs, and increase fully capitated programs, ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group : 1 director

A director at UnitedHealth Group sold 7,000 shares at 415.695USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group Incorporated: 2021 results to date exceeding expect...

Solid earnings results in Q2 2021 support UnitedHealth's strong credit profile

UNH UnitedHealth Gr... (Health Care)

Moody’s rates UnitedHealth Group’s senior notes A3

Approximately $5 billion of new debt securities rated New York , May 17, 2021 – Moody's Investors Service has assigned an A3 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH, senior debt at A3) planned issuance of $5.0 billion of senior unsecured debt...

Valens Research
  • Valens Research
UNH UnitedHealth Gr... (Health Care)

UNH - Embedded Expectations Analysis - 2021 05 14

UnitedHealth Group Incorporated (UNH:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 23.3x Uniform P/E. At these levels, the market has expectations for profitability to remain stable, but management may be concerned about their OptumCare platform, digital solutions, and the potential disruption of their Change Health acquisition Specifically, management may lack confidence in their ability to sustain adjusted earnings per share (EPS) growth, maintain patient growth under their managed Medicaid programs, and increase fully capitated programs, ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group : 1 director

A director at UnitedHealth Group sold 7,000 shares at 415.695USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group Incorporated: 2021 results to date exceeding expect...

Solid earnings results in Q2 2021 support UnitedHealth's strong credit profile

UNH UnitedHealth Gr... (Health Care)

Moody’s rates UnitedHealth Group’s senior notes A3

Approximately $5 billion of new debt securities rated New York , May 17, 2021 – Moody's Investors Service has assigned an A3 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH, senior debt at A3) planned issuance of $5.0 billion of senior unsecured debt...

Valens Research
  • Valens Research
UNH UnitedHealth Gr... (Health Care)

UNH - Embedded Expectations Analysis - 2021 05 14

UnitedHealth Group Incorporated (UNH:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 23.3x Uniform P/E. At these levels, the market has expectations for profitability to remain stable, but management may be concerned about their OptumCare platform, digital solutions, and the potential disruption of their Change Health acquisition Specifically, management may lack confidence in their ability to sustain adjusted earnings per share (EPS) growth, maintain patient growth under their managed Medicaid programs, and increase fully capitated programs, ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group : 1 director

A director at UnitedHealth Group sold 7,000 shares at 415.695USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of ...

UNH UnitedHealth Gr... (Health Care)

UnitedHealth Group Incorporated: 2021 results to date exceeding expect...

Solid earnings results in Q2 2021 support UnitedHealth's strong credit profile

UNH UnitedHealth Gr... (Health Care)

Moody’s rates UnitedHealth Group’s senior notes A3

Approximately $5 billion of new debt securities rated New York , May 17, 2021 – Moody's Investors Service has assigned an A3 senior unsecured debt rating to UnitedHealth Group Incorporated's (UnitedHealth, NYSE: UNH, senior debt at A3) planned issuance of $5.0 billion of senior unsecured debt...

Valens Research
  • Valens Research
UNH UnitedHealth Gr... (Health Care)

UNH - Embedded Expectations Analysis - 2021 05 14

UnitedHealth Group Incorporated (UNH:USA) currently trades above corporate averages relative to UAFRS-based (Uniform) earnings, with a 23.3x Uniform P/E. At these levels, the market has expectations for profitability to remain stable, but management may be concerned about their OptumCare platform, digital solutions, and the potential disruption of their Change Health acquisition Specifically, management may lack confidence in their ability to sustain adjusted earnings per share (EPS) growth, maintain patient growth under their managed Medicaid programs, and increase fully capitated programs, ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch